XML 21 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Available-for-sale Securities
9 Months Ended
Sep. 30, 2016
Investments Debt And Equity Securities [Abstract]  
Available-for-sale Securities

Note 3. Available-for-sale Securities

The following is a summary of available-for-sale securities at September 30, 2016 (in thousands):

 

 

 

September 30, 2016

 

 

 

Amortized Cost

 

 

Gross

Unrealized Gain

 

 

Gross

Unrealized Loss

 

 

Fair Value

 

Money market funds

 

$

2,122

 

 

$

-

 

 

$

-

 

 

$

2,122

 

United States government agency securities

 

 

25,190

 

 

 

4

 

 

 

-

 

 

 

25,194

 

Corporate debt securities

 

 

43,198

 

 

 

19

 

 

 

(17

)

 

 

43,200

 

Marketable equity securities

 

 

-

 

 

 

4,930

 

 

 

-

 

 

 

4,930

 

Total available-for-sale securities

 

$

70,510

 

 

$

4,953

 

 

$

(17

)

 

$

75,446

 

 

The following is a summary of available-for-sale securities at December 31, 2015 (in thousands):

 

 

 

December 31, 2015

 

 

 

Amortized Cost

 

 

Gross

Unrealized Gain

 

 

Gross

Unrealized Loss

 

 

Fair Value

 

Money market funds

 

$

59,302

 

 

$

-

 

 

$

-

 

 

$

59,302

 

Corporate debt securities

 

 

25,747

 

 

 

-

 

 

 

(49

)

 

 

25,698

 

Marketable equity securities

 

 

-

 

 

 

11,163

 

 

 

-

 

 

 

11,163

 

Total available-for-sale securities

 

$

85,049

 

 

$

11,163

 

 

$

(49

)

 

$

96,163

 

 

Available-for-sale securities at September 30, 2016 and December 31, 2015, consisted of the following by contractual maturity (in thousands):

 

 

 

September 30, 2016

 

 

December 31, 2015

 

 

 

Amortized Cost

 

 

Fair Value

 

 

Amortized Cost

 

 

Fair Value

 

One year or less

 

$

66,507

 

 

$

66,512

 

 

$

85,049

 

 

$

85,000

 

Marketable equity securities

 

 

-

 

 

 

4,930

 

 

 

-

 

 

 

11,163

 

Greater than one year and less than five years

 

 

4,003

 

 

 

4,004

 

 

 

-

 

 

 

-

 

Total available-for-sale securities

 

$

70,510

 

 

$

75,446

 

 

$

85,049

 

 

$

96,163

 

 

The following tables show all available-for-sale marketable securities in an unrealized loss position for which an other-than-temporary impairment has not been recognized and the related gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position (in thousands):

 

 

 

September 30, 2016

 

 

 

Less than 12 Months

 

 

12 Months or Greater

 

 

Total

 

 

 

Fair Value

 

 

Unrealized

Loss

 

 

Fair Value

 

 

Unrealized

Loss

 

 

Fair Value

 

 

Unrealized

Loss

 

Corporate debt securities

 

$

20,082

 

 

$

(17

)

 

$

-

 

 

$

-

 

 

$

20,082

 

 

$

(17

)

Total available-for-sale securities

 

$

20,082

 

 

$

(17

)

 

$

-

 

 

$

-

 

 

$

20,082

 

 

$

(17

)

 

 

 

December 31, 2015

 

 

 

Less than 12 Months

 

 

12 Months or Greater

 

 

Total

 

 

 

Fair Value

 

 

Unrealized

Loss

 

 

Fair Value

 

 

Unrealized

Loss

 

 

Fair Value

 

 

Unrealized

Loss

 

Corporate debt securities

 

$

20,170

 

 

$

(46

)

 

$

5,528

 

 

$

(3

)

 

$

25,698

 

 

$

(49

)

Total available-for-sale securities

 

$

20,170

 

 

$

(46

)

 

$

5,528

 

 

$

(3

)

 

$

25,698

 

 

$

(49

)

 

As of September 30, 2016, the Company considered the declines in market value of its marketable securities investment portfolio to be temporary in nature and did not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates, and the Company’s intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment’s cost basis. During the three and nine months ended September 30, 2016 and 2015, the Company did not recognize any other-than-temporary impairment loss. The Company has no current requirement or intent to sell the securities in an unrealized loss position. The Company expects to recover up to (or beyond) the initial cost of investment for securities held.

The Company did not record any gross realized gains from the sale or maturity of available-for-sale investments during the three and nine months ended September 30, 2016 and 2015. The Company did not record any gross realized losses from the sale or maturity of available-for-sale investments during the three and nine months ended September 30, 2016 and 2015.